INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo MINIMS* BENOXINATE HYDROCHLORIDE 0,4%
        0504143

SCHEDULING STATUS:
Schedule 4

PROPRIETARY NAME
(and dosage form):

MINIMS* BENOXINATE HYDROCHLORIDE 0,4%
Eye Drops

COMPOSITION:
(per dispensing unit of 0,5 mL)
Benoxinate Hydrochloride 2 mg

PHARMACOLOGICAL CLASSIFICATION:
A 15.4 Ophthalmic preparations: other

PHARMACOLOGICAL ACTION:
Benoxinate hydrochloride is an effective surface anaesthetic which acts by blocking sensory nerve endings near the site of application. The solution produces little conjunctival irritation or hyperaemia and has no effect on the pupil; it has a bacteriostatic action and reduces the risk of exposure keratitis.

INDICATIONS:
Used in applanation tonometry and for the fitting of contact lenses.

CONTRA-INDICATIONS:
Caution should be observed when benoxinate hydrochloride is used in patients with allergies, cardiac disease, hyperthyroidism, or open lesions.

DOSAGE AND DIRECTIONS FOR USE:
Adults and children: To be used as directed by the ophthalmologist. 1-3 drops of 0,4% solution, depending on the degree of anaesthesia required. Onset of action is 6-20 seconds and duration of effect is 15 minutes.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Systemic toxicity is rarely seen following ocular administration, but is identical to that for amethocaine hydrochloride; namely cardiovascular collapse due to idiosyncrasy and occasionally, convulsions and hyperexcitability.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Not applicable.

IDENTIFICATION:
Clear, colourless solution.

PRESENTATION:
Sterile, single-dose disposable eye drops in cartons of 20 units, each containing approximately 0,5 mL.

STORAGE INSTRUCTIONS:
Store in the refrigerator between 2-8°C protected from strong light. DO NOT FREEZE. KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
C/15.4/44

NAME AND BUSINESS ADDRESS OF APPLICANT:
Smith & Nephew Pharmaceuticals (Pty) Ltd
30 Gillitts Road
Pinetown 3610

Manufactured by:
Chauvin Pharmaceuticals Ltd.
Romford RM3 8SL, England

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
February 1, 2000

* Trademark

PMBHT04ZA

Updated on this site: December 2001

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2000